| |
Home »
News » 01/06 »
Testicular cancer survivors 'have increased heart risk'
Testicular cancer survivors 'have increased heart
risk'
Date published: 20/01/2006
Men who
have survived testicular cancer have an increased risk of developing
cardiovascular disease, a new study suggests. Dutch researchers, writing in the
Journal of Clinical Oncology, have called for
these patients to undergo cardiac monitoring as part of their follow-up care.
The study examined 2,412 men at least five years after they had
survived the cancer between 1965 and 1995. Their cardiovascular disease rates
were compared to those of the general public as a control. Results revealed
that, at a median follow-up of over 18 years, survivors of testicular cancer
had a modestly improved risk of developing cardiovascular disease, and that
recent smoking increased the risk of myocardial infarction 2.6-fold.
Patients who had received radiation therapy to the chest had a three
times higher risk of heart disease, whilst those that were treated with the
chemotherapy combination PVB (cisplatin, vinblastine, and bleomycin) had a
1.9-fold increase in their risk of myocardial infarction.
The research
team concluded: "Testicular cancer survivors experience a moderately increased
myocardial infarction risk at young ages. Physicians should be aware of excess
cardiovascular disease risk associated with mediastinal radiotherapy, PVB
chemotherapy, and recent smoking." They urged survivors of testicular cancer to
consult with their GP regarding cardiac monitoring.
© Adfero Ltd
Disclaimer
AllAboutMedicalSales excludes any warranty, express or implied, as to
the quality, accuracy, timeliness, completeness or fitness for a particular
purpose of this briefing. AllAboutMedicalSales will not be liable for any
claims, penalties, losses, damages, costs, or expenses arising from the use of
or inability to use this briefing or from any unauthorised access to or
alteration of the Briefing. AllAboutMedicalSales makes no warranty that the
contents of this briefing are compatible with all computer systems and
browsers.
|